Mechanisms of disease: Prostate cancer - A model for cancer chemoprevention in clinical practice

Edith D. Canby-Hagino, Ian M. Thompson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Prostate cancer is a significant cause of cancer death, making it an attractive target for chemoprevention. Epidemiologic studies and the Prostate Cancer Prevention Trial indicate that chemoprevention is possible. Strategies for prevention include hormonal manipulation and limiting accumulation of genetic damage with anti-inflammatory agents and/or dietary antioxidants. Development of an effective chemoprevention strategy for prostate cancer is evolving and will likely serve as a model for chemoprevention of other adult malignancies.

Original languageEnglish (US)
Pages (from-to)255-261
Number of pages7
JournalNature Clinical Practice Oncology
Volume2
Issue number5
DOIs
StatePublished - May 2005

Fingerprint

Chemoprevention
Prostatic Neoplasms
Neoplasms
Epidemiologic Studies
Cause of Death
Anti-Inflammatory Agents
Antioxidants

Keywords

  • 5α-reductase
  • Antioxidants
  • Chemoprevention
  • Inflammation
  • Prostate cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Mechanisms of disease : Prostate cancer - A model for cancer chemoprevention in clinical practice. / Canby-Hagino, Edith D.; Thompson, Ian M.

In: Nature Clinical Practice Oncology, Vol. 2, No. 5, 05.2005, p. 255-261.

Research output: Contribution to journalArticle

@article{030706a574d04b88ba1316e968e963d2,
title = "Mechanisms of disease: Prostate cancer - A model for cancer chemoprevention in clinical practice",
abstract = "Prostate cancer is a significant cause of cancer death, making it an attractive target for chemoprevention. Epidemiologic studies and the Prostate Cancer Prevention Trial indicate that chemoprevention is possible. Strategies for prevention include hormonal manipulation and limiting accumulation of genetic damage with anti-inflammatory agents and/or dietary antioxidants. Development of an effective chemoprevention strategy for prostate cancer is evolving and will likely serve as a model for chemoprevention of other adult malignancies.",
keywords = "5α-reductase, Antioxidants, Chemoprevention, Inflammation, Prostate cancer",
author = "Canby-Hagino, {Edith D.} and Thompson, {Ian M.}",
year = "2005",
month = "5",
doi = "10.1038/ncponc0172",
language = "English (US)",
volume = "2",
pages = "255--261",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Mechanisms of disease

T2 - Prostate cancer - A model for cancer chemoprevention in clinical practice

AU - Canby-Hagino, Edith D.

AU - Thompson, Ian M.

PY - 2005/5

Y1 - 2005/5

N2 - Prostate cancer is a significant cause of cancer death, making it an attractive target for chemoprevention. Epidemiologic studies and the Prostate Cancer Prevention Trial indicate that chemoprevention is possible. Strategies for prevention include hormonal manipulation and limiting accumulation of genetic damage with anti-inflammatory agents and/or dietary antioxidants. Development of an effective chemoprevention strategy for prostate cancer is evolving and will likely serve as a model for chemoprevention of other adult malignancies.

AB - Prostate cancer is a significant cause of cancer death, making it an attractive target for chemoprevention. Epidemiologic studies and the Prostate Cancer Prevention Trial indicate that chemoprevention is possible. Strategies for prevention include hormonal manipulation and limiting accumulation of genetic damage with anti-inflammatory agents and/or dietary antioxidants. Development of an effective chemoprevention strategy for prostate cancer is evolving and will likely serve as a model for chemoprevention of other adult malignancies.

KW - 5α-reductase

KW - Antioxidants

KW - Chemoprevention

KW - Inflammation

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=20444471578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444471578&partnerID=8YFLogxK

U2 - 10.1038/ncponc0172

DO - 10.1038/ncponc0172

M3 - Article

C2 - 16264961

AN - SCOPUS:20444471578

VL - 2

SP - 255

EP - 261

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 5

ER -